Profile
Sector:
HealthcareIndustry:
Medical Instruments & SuppliesCountry:
United StatesIPO:
24 February 1992Website:
http://www.staar.comNext earnings report:
02 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 19:50:11 GMTDividend
Analysts recommendations
Institutional Ownership
STAA Latest News
Examine how Staar Surgical's (STAA) international revenue results impact financial analysts' forecasts on Wall Street and the stock's future outlook.
Staar Surgical (STAA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
STAAR Surgical (NASDAQ: STAA) received an upgrade from William Blair on Friday. The stock has been moved from Market Perform to Outperform status.
The headline numbers for Staar Surgical (STAA) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
STAAR Surgical Company (STAA) Q4 2023 Earnings Call Transcript
Staar Surgical (STAA) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.14 per share a year ago.
STAAR Surgical Company (NASDAQ:STAA ) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ET Company Participants Brian Moore - Vice President-Investor Relations & Corporate Development Tom Frinzi - President & Chief Executive Officer Patrick Williams - Chief Financial Officer. Conference Call Participants Anthony Petrone - Mizuho Xuyang Li - Jefferies John Young - Canaccord George Sellers - Stephens Margaret Kaczor Andrew - William Blair Steve Lichtman - Oppenheimer Operator Good day ladies and gentlemen.
STAAR Surgical Company has developed the EVO ICL Lens to treat nearsightedness, offering clear vision without the hassle of contact lenses or glasses. The EVO ICL Lens has gained market share, with the EVO category capturing over 10% of the global market. STAAR's sales and operating profits have been growing steadily, with a net cash position and a valuation of $2.5 billion. However, sales growth is slowing down.
STAAR Surgical Company's Q2 FY'23 earnings missed consensus estimates. The key revenue driver for STAA is its Implantable Collamer Lenses, which saw a 21% YoY increase in unit volumes. Despite potential topline growth, the economic realities and valuation multiples suggest STAA is a hold in my opinion.
Staar Surgical (STAA) came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.42 per share a year ago.
What type of business is STAAR Surgical?
STAAR Surgical Company is a leading manufacturer of lenses used worldwide in corrective surgery. The corporation has been in operation since 1982 and is based in Springfield, Massachusetts. STAAR Surgical Company designs, develops, manufactures, and markets implantable lenses for the eyes and systems used to deliver lenses to the eye. STAAR conducts business worldwide, with approximately 95% of its sales volume coming from outside the US. The company sells its products in over 75 countries, through direct sales in Japan, Spain, the US, Germany, Canada, the UK, and Singapore, and through distributors and representatives in China, Korea, and India.
What sector is STAAR Surgical in?
STAAR Surgical is in the Healthcare sector
What industry is STAAR Surgical in?
STAAR Surgical is in the Medical Instruments & Supplies industry
What country is STAAR Surgical from?
STAAR Surgical is headquartered in United States
When did STAAR Surgical go public?
STAAR Surgical initial public offering (IPO) was on 24 February 1992
What is STAAR Surgical website?
https://www.staar.com
Is STAAR Surgical in the S&P 500?
No, STAAR Surgical is not included in the S&P 500 index
Is STAAR Surgical in the NASDAQ 100?
No, STAAR Surgical is not included in the NASDAQ 100 index
Is STAAR Surgical in the Dow Jones?
No, STAAR Surgical is not included in the Dow Jones index
When does STAAR Surgical report earnings?
The next expected earnings date for STAAR Surgical is 02 August 2024